Galnmax Pharmaceuticals Private Limited
About Galnmax Pharmaceuticals Private Limited
Data last updated:
Galnmax Pharmaceuticals Private Limited is a private limited company based in Ajmer, Rajasthan, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 02 May 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24290RJ2019PTC064783. Its GSTIN is 09AAHCG8018J1ZA (Uttar Pradesh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Megha Srivastava Chauhan and Hem Prabha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 29 Income Tax Colony, Ajmer, Rajasthan, India – 305001.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.32 Lakh, a growth of 91% compared to the previous year. For the same year it recorded a net loss of ₹24,875 (net margin -3.9%) and EBITDA of -₹6,847 (EBITDA margin -1.1%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 37% over five years.
Company details
Contact details
Galnmax Pharmaceuticals Private Limited's registered office is in Ajmer, Rajasthan. Its e-mail address is in the company report.
- Email
- Registered Address29 Income Tax Colony, Ajmer, Rajasthan, India – 305001
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Galnmax Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Galnmax Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Galnmax Pharmaceuticals Private Limited, buy the company report.
Financials of Galnmax Pharmaceuticals Private Limited
FY 2025 filings availableGalnmax Pharmaceuticals Private Limited reported revenue of ₹6.32 Lakh (up 91% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 37% over five years, including 91% growth in the latest year. EBITDA fell 85% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹6,847 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹24,875 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -1.1% | ||||
| Net Profit Margin | -3.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Galnmax Pharmaceuticals Private Limited, buy the company report.
Board of directors of Galnmax Pharmaceuticals Private Limited
Galnmax Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Megha Srivastava Chauhan | Director | 02 May 2019 | 7 Years 5 Months | Current |
| Hem Prabha | Director | 02 May 2019 | 7 Years 5 Months | Current |
Legal cases
No court or tribunal cases involving Galnmax Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Galnmax Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Galnmax Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAHCG8018J1ZA | Uttar Pradesh | Active | 28 May 2019 |
To see the full GST registrations and return filing status of Galnmax Pharmaceuticals Private Limited, buy the company report.
Recent activity
Galnmax Pharmaceuticals Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Hem Prabha was appointed as Director on 02 May 2019.
Frequently asked questions
Galnmax Pharmaceuticals is an active private limited company based in Ajmer, Rajasthan, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 02 May 2019 (7+ years old) and is registered under CIN U24290RJ2019PTC064783.
Galnmax Pharmaceuticals has 2 current directors:
- Megha Srivastava Chauhan - Director
- Hem Prabha - Director
The latest financial statements of Galnmax Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Galnmax Pharmaceuticals is 09AAHCG8018J1ZA, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Galnmax Pharmaceuticals is U24290RJ2019PTC064783. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Galnmax Pharmaceuticals was incorporated on 02 May 2019, making it 7+ years old. It is registered with the Registrar of Companies, Jaipur.
Hem Prabha was appointed as Director on 02 May 2019. Megha Srivastava Chauhan was appointed as Director on 02 May 2019.
The registered office of Galnmax Pharmaceuticals is at 29 Income Tax Colony, Ajmer, Rajasthan, India – 305001.
Galnmax Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Galnmax Pharmaceuticals can be reached at its registered office: 29 Income Tax Colony, Ajmer, Rajasthan, India – 305001.